• Japanese
  • Korean
  • Chinese
Cover Image

Medical Imaging Markets

Abstract

Description

The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about 108 million X-ray exams per year. MRI is second with 26 million examinations per year. PET, SPECT, CT and nuclear medicine rank third with 30 million examinations per year. Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As a result of these medical imaging advancements, the multi-slice systems are generating large volumes of data, and this creates demand for data storage, 3-D visualization and analysis. As such, the global medical imaging industry is primed to experience significant growth through the next decade. This report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and marketshare data are also included.

Table of Contents

1. Overview

  • 1.1 Statement of This Report
  • 1.2 Scope of This Report
  • 1.3 Methodology
  • 1.4 Executive Summary

2. Medical Imaging Technologies: An Overview

  • 2.1 X-Ray 26
    • 2.1.1 Applications of X-Ray
  • 2.2 Computed Radiography
  • 2.3 Digital Radiography
  • 2.4 Fluoroscopy and C-Arms Systems
    • 2.4.1 Undercouch (Conventional) System
    • 2.4.2 Overcouch (Remote-Controlled) Systems
    • 2.4.3 Multipurpose Systems
    • 2.4.4 Clinical Procedures Using Radiography/Fluoroscopy Systems
      • 2.4.4.1 Barium Studies
      • 2.4.4.2 Biopsy
      • 2.4.4.3 Angiography
      • 2.4.4.4 Other Clinical Procedures
    • 2.4.5 The Available R/F Systems
    • 2.4.6 The Available Overcouch R/F Systems
    • 2.4.7 The Available Multipurpose R/F Systems
    • 2.4.8 A Buyer's Guide for C-Arm Systems
      • 2.4.8.1 Procedure Room Layout
      • 2.4.8.2 Procedures Using C-Arms Systems
      • 2.4.8.3 Available C-Arms Systems
      • 2.4.8.4 Comparison of C-Arms Systems
      • 2.4.8.5 Popular C-Arms Brands
      • 2.4.8.6 Return on Investment for C-Arm Systems
  • 2.5 Mammography
    • 2.5.1 Film/Screen Systems for Mammography
    • 2.5.2 Full Field Digital Mammography
      • 2.5.2.1 Clinical Applications of Mammography Systems
      • 2.5.2.2 Components of a Mammography System
      • 2.5.2.3 Comparison of Mammography Technologies
    • 2.5.3 Selected Mammography Systems
      • 2.5.3.1 The available FFDM systems
  • 2.6 Bone Densitometry Scanners
    • 2.6.1 Bone Densitometry Scanners: Purchase Options
  • 2.7 Computed Tomography
    • 2.7.1 Conventional CT Scanners
    • 2.7.2 Spiral CT Scanners
    • 2.7.3 Multislice CT Scanners
    • 2.7.4 Electron Beam CT Scanners
    • 2.7.6 Tube Voltage
    • 2.7.7 Tube Current
    • 2.7.8 Pitch
    • 2.7.9 Gantry Rotation Time
    • 2.7.10 Scan Volume
    • 2.7.11 Dose Reduction and Optimization Strategies
    • 2.7.12 Market Leaders in CT Scanners
    • 2.7.13 16-Slice CT Scanners
    • 2.7.14 32- to 40-Slice CT Scanners
    • 2.7.15 64-Slice CT Scanners
    • 2.7.16 64 Slice Cardiac CT Scanners
    • 2.7.17 Wide Bore CT Scanners
    • 2.7.18 Greater Than 64-Slice CT Scanners
  • 2.8 MRI Scanners
    • 2.8.1 Types of MRI Scanners
      • 2.8.1.1 High-Field MRI Scanners
      • 2.8.1.2 Low-Field MRI Scanners
      • 2.8.1.3 Stand-Up/Upright MRI Scanners
    • 2.8.2 Leading Vendors and their Models
    • 2.8.3 Key Purchasing Factors to Consider
      • 2.8.3.1 Technical Features
      • 2.8.3.2 Ease of Use and Safety
      • 2.8.3.3 MRI Machine Cost and Price
  • 2.9 Ultrasound Scanners
    • 2.9.1 Types of Ultrasound Imaging
  • 2.10 Nuclear Imaging
    • 2.10.1 Single Photon Emission Computed Tomography
      • 2.10.1.1 Advantages of SPECT Imaging
      • 2.10.1.2 Disadvantages of SPECT Imaging
      • 2.10.1.3 Medical Applications of SPECT Systems
      • 2.10.1.4 Leading SPECT System Manufacturers
      • 2.10.1.5 The Market Leading SPECT Systems
      • 2.10.1.6 U.S. SPECT Statistics
      • 2.10.1.7 Installed Devices and Patient Waiting Times in the U.S. for SPECT Imaging
      • 2.10.1.8 Projected Purchases of SPECT Systems in the U.S.
      • 2.10.1.9 Radionuclides Used in SPECT Imaging
    • 2.10.2 SPECT/CT
      • 2.10.2.1 Clinical Applications of SPECT/CT
      • 2.10.2.2 The Market Leading SPECT/CT Systems
    • 2.10.3 Positron Emission Tomography
      • 2.10.3.1 Medical Applications of PET
    • 2.10.4 PET/CT
      • 2.10.4.1 Clinical Applications of PET/CT in Oncology
      • 2.10.4.2 Clinical Applications of PET/CT in Head and Neck Cancer
      • 2.10.4.3 Clinical Applications of PET/CT in Lung Cancer
      • 2.10.4.4 Clinical Applications of PET/CT in Breast Cancer
      • 2.10.4.5 Clinical Application of PET/CT in Prostate Cancer
      • 2.10.4.6 Clinical Application of PET/CT in Lymphomas
      • 2.10.4.7 Clinical Application of PET/CT in Digestive Tract Tumors
      • 2.10.4.8 Clinical Application of PET/CT in Cardiology
  • 2.11 Nuclear Medicine
    • 2.11.1 Diagnostic Techniques in Nuclear Medicine
    • 2.11.2 Diagnostic Radiopharmaceuticals
      • 2.11.2.1 Suppliers of Radioisotopes
      • 2.11.2.2 Reactor Isotopes
      • 2.11.2.3 Cyclotron Isotopes

3. Medical Indications for the Currently Available Imaging Modalities

  • 3.1 Medical Imaging in Cancer Care
    • 3.1.1 Global Incidence of Cancer
    • 3.1.2 Incidence of Cancer in the U.S.
    • 3.1.3 Cancer Incidence in Europe
    • 3.1.4 Relative Use of Imaging Modalities in Oncology
  • 3.2 Global Incidence of Cardiovascular Diseases
    • 3.2.1 Cardiovascular Diseases in the U.S. 8
    • 3.2.2 Cardiovascular Disease in Europe
      • 3.2.2.1 Mortality Due to Heart Diseases in Europe
    • 3.2.3 Relative Use of Imaging Modalities in Cardiology
  • 3.3 Global Incidence of Neurological Disorders
    • 3.3.1 Neurological Diseases in the U.S.
    • 3.3.2 Neurological Diseases in Europe
    • 3.3.3 Relative Use of Imaging Modalities in Neurology
  • 3.4 Musculoskeletal Disorders
    • 3.4.1 Relative Use of Imaging Modalities in Bone Scans

4. Medical Imaging: Market Analysis

  • 4.1 Global Medical Imaging Market
    • 4.1.1 Global Medical Imaging Market by Geography
    • 4.1.2 Global Medical Imaging Market by Modality
    • 4.1.3 Global Medical Imaging Market by Care Setting
    • 4.1.4 U.S. Market for Medical Imaging Modalities
      • 4.1.4.1 Cost of Hospital-Based Imaging Services in the U.S.
      • 4.1.4.2 Cost of Imaging Procedures in Freestanding Imaging Centers in the U.S.
      • 4.1.4.3 Hospital-Based vs. Freestanding Outpatient Imaging Services in the U.S.
      • 4.1.4.4 Forecasting Imaging Volume under Healthcare Reform in the U.S.
      • 4.1.4.5 Medical Imaging Forecast under Healthcare Reform in the U.S
      • 4.1.4.6 Medicare Spending for Imaging Services in the U.S.
      • 4.1.4.7 Rapid Growth in CT and MRI Scans in Medicare Volume in the U.S.
      • 4.1.4.8 The Declining Medicare Spending on Medical Imaging in the U.S.
      • 4.1.4.9 Small Share of Imaging in Medicare Claims in the U.S.
      • 4.1.4.10 Slow Growth of Medical Imaging in the U.S.
      • 4.1.4.11 Historical Growth of Medical Imaging in the U.S.
      • 4.1.4.12 Imaging-Center Chains in the U.S., 2012
    • 4.1.5 Medical Imaging in Canada
      • 4.1.5.1 Number of Selected Imaging Modalities in Canada
      • 4.1.5.2 Segmentation of Diagnostic Imaging Equipment in Canada 1
    • 4.1.6 Medical Imaging Market in Germany
    • 4.1.7 Medical Imaging Market in France
    • 4.1.8 Medical Imaging Market in Italy
    • 4.1.9 Medical Imaging in Spain
    • 4.1.10 Medical Imaging Market in the U.K.
      • 4.1.10.1 Growth of Imaging Procedures in U.K.
      • 4.1.10.2 Projected and Actual Replacement of CT Scanners in U.K.
      • 4.1.10.3 Relative Strengths of Medical Imaging Market in Europe by Country
    • 4.1.11 Growth of Medical Imaging in Pharmerging Markets
    • 4.1.12 Medical Imaging Market in Asia/Pacific
      • 4.1.12.1 Medical Imaging Market in Japan
      • 4.1.12.2 Medical Imaging Market in China
      • 4.1.12.3 Medical Imaging Market in South Korea
      • 4.1.12.4 Medical Imaging Market in Australia
      • 4.1.12.5 Medical Imaging Market in India
  • 4.2 Global Market for X-Ray Systems
    • 4.2.1 Growing Market for Mobile X-Ray Systems
    • 4.2.2 Global Market for Fluoroscopy and Mobile C-Arms
    • 4.2.3 Global Market for DR and CR X-Ray Systems
    • 4.2.4 U.S. Market for X-Ray Systems
    • 4.2.5 European Markets for General X-Ray Systems
    • 4.2.6 X-Ray Market in China
    • 4.2.7 Indian Market for X-Ray Systems
  • 4.3 Global Market for Full-Field Digital Mammography Systems
    • 4.3.1 Market Leaders in FFDM Systems
    • 4.3.2 U.S. Market for Full-Field Digital Mammography Systems
  • 4.4 Global Market for Bone Densitometry Systems
  • 4.5 Global Market for CT Scanners
    • 4.5.1 U.S. Market for CT Scanners
      • 4.5.1.1 CT Systems by Slice Count in the U.S.
      • 4.5.1.2 CT Utilization Rates in the U.S.
      • 4.5.1.3 Increased CT Volume Growth in the U.S.
      • 4.5.1.4 CT Procedure Growth in the U.S.
      • 4.5.1.5 CT Utilization Percentage by System Age in the U.S.
      • 4.5.1.6 Service Providers for CT Systems in the U.S.
      • 4.5.1.7 CT Service Cost in the U.S.
      • 4.5.1.8 The Average Age of CT Systems
      • 4.5.1.9 Changes to Reimbursement for CT Imaging in the U.S., 2013
      • 4.5.1.10 Number of Self-Referred and Non-Self Referred CT Services in the U.S.
      • 4.5.1.11 Self-Referred and Non-Self-Referred CT Expenditure in the U.S.
    • 4.5.2 Volume of CT Exams in Canada
    • 4.5.3 European Market for CT Systems
      • 4.5.3.1 Western European CT Market
      • 4.5.3.2 CT Scanners in Austria and Switzerland by Slice Count
      • 4.5.3.3 CT Scanners in Benelux by Slice Count
      • 4.5.3.4 CT Scanners in France by Slice Count
      • 4.5.3.5 CT Scanners in Germany by Slice Count
      • 4.5.3.6 CT Scanners in Italy by Slice Count
      • 4.5.3.7 CT Scanners in Spain and Portugal by Slice Count
      • 4.5.3.8 CT Scanners in U.K. and Ireland by Slice Count
    • 4.5.4 CT Exams in OECD Countries
      • 4.5.4.1 CT Scanners in OECD Countries
    • 4.5.5 CT Scanners Market in India
    • 4.5.5.1 Indian CT Scanners Market by Segment
  • 4.6 Global MRI Market
    • 4.6.1 U.S. Market for MRI
      • 4.6.1.1 Deployed MRI Systems by Field Strength in the U.S.
      • 4.6.1.2 MRI Procedure Forecast in the U.S.
      • 4.6.1.3 MRI Cost in the U.S.
      • 4.6.1.4 MRI Utilization Percentage by System Age in the U.S.
      • 4.6.1.5 Service Providers for MRI Systems in the U.S.
      • 4.6.1.6 Average MRI Service Cost in the U.S.
      • 4.6.1.7 Aging of Installed MRI Scanners in the U.S.
      • 4.6.1.8 MRI Utilization Rates in the U.S.
      • 4.6.1.9 Larger Increase among Self-Referred Services in MRI and CT
      • 4.6.1.10 Utilization by Setting and Medicare Physician Fee Schedule Spending in the U.S.
      • 4.6.1.11 Number of Self-Referred and Non-Self-Referred MRI and CT Services in the U.S.
      • 4.6.1.12 Spending for MRI Services in the U.S.
      • 4.6.1.13 CT and MRI Systems in Six States of the U.S.
      • 4.6.1.14 Projected Revenue Increase for MRI and CT in the U.S.
      • 4.6.1.15 Projected Need and Capacities for MRI and CT in Selected U.S. States
      • 4.6.1.16 Number of MRI and CT Scans in the U.S.
    • 4.6.2 Volume of MRI Exams in Canada
      • 4.6.2.1 Wait Times for MRI Scans in Canada
    • 4.6.3 European MRI Market
      • 4.6.3.1 MRI and CT Exams in U.K.
      • 4.6.3.2 Number of Imaging Machines Purchased by NHS
    • 4.6.4 MRI: Installed Units in OECD Countries
      • 4.6.4.1 MRI Exams in OECD Countries
    • 4.6.5 Market for MRI Scanners in Japan
    • 4.6.6 Market for MRI Systems in India
    • 4.6.7 MRI Market in China
  • 4.7 Global Market for Ultrasound Systems
    • 4.7.1 Ultrasound Market by Clinical Specialties
    • 4.7.2 Growth Rate for Ultrasound in Different Clinical Specialties
    • 4.7.3 U.S. Ultrasound Market in Radiology
    • 4.7.4 Ultrasound Market in Europe
    • 4.7.5 Ultrasound Market in China
    • 4.7.6 Indian Market for Ultrasound Equipment
      • 4.7.6.1 Indian Ultrasound Equipment Market: Unit-Wise
      • 4.7.6.2 Indian Color Doppler Equipment Market: Value-Wise
      • 4.7.6.3 Indian Color Doppler Equipment Market: Unit-Wise
  • 4.8 Global Market for Nuclear Imaging Systems
    • 4.8.1 Global Nuclear Imaging Market Share by Vendor
    • 4.8.2 U.S. Market for Nuclear Imaging Systems
    • 4.8.3 European Market for Nuclear Imaging Systems
    • 4.8.4 Global Market for PET Systems
      • 4.8.4.1 PET and PET/CT Market by Geography
      • 4.8.4.2 Growth Rate for PET in the Global Market
    • 4.8.5 U.S. Market for PET Systems
      • 4.8.5.1 Market for Refurbished PET Systems in the U.S.
      • 4.8.5.2 Average Selling Price of Nuclear Equipment in the U.S. and U.K
      • 4.8.5.3 Nuclear Medicine Procedure Volumes in the U.S.
      • 4.8.5.4 Growth Rate for PET Medical Imaging in the U.S.
      • 4.8.5.5 Distribution of PET Imaging Sites in the U.S.
      • 4.8.5.6 Number of PET Imaging Sites and Clinical PET Patient Studies in the U.S.
      • 4.8.5.7 Current PET Capability in the U.S.
      • 4.8.5.8 The Installed Base of Fixed PET/CT and PET Scanners in the U.S.
      • 4.8.5.9 Mobile vs. Fixed PET/CT or PET Sites in the U.S.
      • 4.8.5.10 Fixed and Mobile PET/CT or PET Sites and Units
      • 4.8.5.11 Growth in PET Patient Studies
      • 4.8.5.12 Percentage of Sites Performing Research vs. Clinical Studies Using PET/CT or PET
      • 4.8.5.13 PET/CT and PET Oncology Study in the U.S.
      • 4.8.5.14 Percent Distribution of PET/CT by Number of CT Slices in the U.S.
      • 4.8.5.15 U.S. Cardiac PET/CT Market
    • 4.8.6 Global Orders for PET/MR Systems
      • 4.8.6.1 U.S. Orders for PET/MR
    • 4.8.7 Status of PET Imaging in Canada
      • 4.8.7.1 Funding for PET Scans in Canada
    • 4.8.8 Growth of PET and PET/CT Centers in Europe
    • 4.8.9 Growth of PET and PET/CT Centers in Emerging Markets
    • 4.8.10 Indian Market for Nuclear Medicine Equipment
  • 4.9 SPECT Market in the U.S.
    • 4.9.1 Average Income from One SPECT Imaging System
    • 4.9.2 SPECT in Canada

5. Relative Use of Imaging Modalities in Future

6. Company Profiles

  • 6.1 3mensio Medical Imaging B.V.
    • 6.1.1 CAAS A-Valve
    • 6.1.2 CAAS QCA
    • 6.1.3 CAAS QCA 2-D Bifurcation
    • 6.1.4 CAAS QCA 3-D
    • 6.1.5 CAAS QCA for Research
    • 6.1.6 CAAS QVA
    • 6.1.7 CAAS QVA 3-D
    • 6.1.8 CAAS QVA for Research
    • 6.1.9 CAAS LVA
    • 6.1.10 CAAS RVA
    • 6.1.11 CAAS MRV
    • 6.1.12 CAAS MRV FARM
    • 6.1.13 CAAS MR Flow
    • 6.1.14 3mensio Aortic Root
    • 6.1.15 3mensio Mitral Valve
    • 6.1.16 3mensio Vascular
    • 6.1.17 3-D Visual Component
    • 6.1.18 CAAS Intravascular
  • 6.2 Agfa Healthcare NV
    • 6.2.1 IMPAX Business Intelligence
    • 6.2.2 Cardiology Entry Level Solution
    • 6.2.3 Cloud and Managed Services
    • 6.2.4 CR 10-X
    • 6.2.5 CR 12-X
    • 6.2.6 CR 30-X
    • 6.2.7 CR 30-Xm
    • 6.2.8 DX-G
    • 6.2.9 DX-M
    • 6.2.10 Conventional Imaging and Processing
    • 6.2.11 SKINTELL
    • 6.2.12 IMPAX Orthopedic Tools
    • 6.2.13 IMPAX PET/CT Viewing
    • 6.2.14 IMPAX Virtual Colonoscopy
    • 6.2.15 IMPAX Volume Viewing
    • 6.2.16 IMPAX X-Ray Angio Analysis
    • 6.2.17 Oasis for IMPAX
    • 6.2.18 OrthoView for IMPAX
    • 6.2.19 DX-D Retrofit
    • 6.2.20 DX-D 100
    • 6.2.21 DX-D 300
    • 6.2.22 DX-D 400
    • 6.2.23 DX-D 600
    • 6.2.24 DX-D 800
    • 6.2.25 DX-D 10
    • 6.2.26 DX-D 20
    • 6.2.27 DX-D 25C
    • 6.2.28 DX-D 30C
    • 6.2.29 DX-D 35C
  • 6.3 B-K Medical ApS
    • 6.3.1 Flex Focus 800
    • 6.3.2 Flex Focus 500
    • 6.3.3 Flex Focus 400
    • 6.3.4 UltraView 800
    • 6.3.5 Flex Focus 400
    • 6.3.6 Flex Focus 200
  • 6.4 Canon U.S.A., Inc.
    • 6.4.1 Digital Detectors
    • 6.4.2 Digital Radiography Solutions
      • 6.4.2.1 RadPRO FM
      • 6.4.2.2 RadPRO ELITE
      • 6.4.2.3 RadPRO URS
    • 6.4.3 Digital Radiography and Fluoroscopy Solution
      • 6.4.3.1 RadPRO D2-50RF
  • 6.5 Biosound Esaote, Inc.
    • 6.5.1 Ultrasound Solutions
      • 6.5.1.1 MyLab Twice
      • 6.5.1.2 MyLab ClassC
      • 6.5.1.3 MyLab Gold Platform
      • 6.5.1.4 MyLab Seven
      • 6.5.1.5 MyLab 50 Family
      • 6.5.1.6 MyLab 40 Family
      • 6.5.1.7 MyLab Alpha
      • 6.5.1.8 MyLab 30 Gold Cardiovascular
      • 6.5.1.9 MyLab 30CV
      • 6.5.1.10 MyLab 25 Gold
      • 6.5.1.11 MyLab 25
      • 6.5.1.12 MyLab 20 Plus
      • 6.5.1.13 MyLab 15/20 Family
      • 6.5.1.14 MyLab Five
      • 6.5.1.15 MyLab One
      • 6.5.1.16 MyLab Guide
    • 6.5.2 Dedicated Musculoskeletal MRI
      • 6.5.2.1 G-Scan Brio
      • 6.5.2.2 G-Scan
      • 6.5.2.3 O-Scan
      • 6.5.2.4 S-Scan
      • 6.5.2.5 Opera
      • 6.5.2.6 C-Scan
  • 6.6 GE Healthcare
    • 6.6.1 Bone Health Imaging Products
      • 6.6.1.1 Lunar iDXA
      • 6.6.1.2 Prodigy
      • 6.6.1.3 DPX Bravo
      • 6.6.1.4 DPX NT
    • 6.6.2 Computed Tomography Products
      • 6.6.2.1 Discovery CT 750 HD FREEdom Edition
      • 6.6.2.2 Optima CT660 FREEdom Edition
      • 6.6.2.3 Optima CT660
      • 6.6.2.4 Optima CT540
      • 6.6.2.5 Optima CT580 W
      • 6.6.2.6 BrightSpeed Elite
      • 6.6.2.7 Discovery CT590 RT
    • 6.6.3 Magnetic Resonance Imaging
      • 6.6.3.1 Discovery MR750w 3.0T
      • 6.6.3.2 Optima MR450w 1.5T with GEM Suite
      • 6.6.3.3 Optima MR430s 1.5T
      • 6.6.3.4 Optima MR360 1.5T
      • 6.6.3.5 Brivo MR355 1.5T
      • 6.6.3.6 Signa HDxt 3.0T
    • 6.6.4 Mammography Systems
      • 6.6.4.1 Senographe Essential
      • 6.6.4.2 Senographe Essential e
      • 6.6.4.3 Senographe Care
      • 6.6.4.4 Senographe DS
    • 6.6.5 Nuclear Imaging
      • 6.6.5.1 Optima PET/CT 560
      • 6.6.5.2 Discovery PET/CT 710
      • 6.6.5.3 Discovery PET/CT 610
    • 6.6.6 Fixed RAD Systems
      • 6.6.6.1 Discovery XR 656
      • 6.6.6.2 Definium 5000
      • 6.6.6.3 Proteus XR/a
      • 6.6.6.4 Brivo XR 385
    • 6.6.7 Mobile X-Ray Systems
      • 6.6.7.1 Optima XR 220 amx
      • 6.6.7.2 Optima XR 200 amx
      • 6.6.7.3 Brivo XR 285 amx
    • 6.6.8 Radiography and Fluoroscopy
      • 6.6.8.1 Precision 500D
      • 6.6.8.2 Precision RXi
    • 6.6.9 Surgical Imaging Systems
      • 6.6.9.1 OEC 9900 Elite Mobile C-Arm
      • 6.6.9.2 OEC 9800 Plus
      • 6.6.9.3 InstalTrak 3500 Plus
      • 6.6.9.4 Nu BOOM M4
      • 6.6.9.5 Nu BOOM M2
    • 6.6.10 Ultrasound Systems
      • 6.3.10.1 Vscan Pocket Ultrasound
      • 6.6.10.2 LOGIQ S8
      • 6.6.10.3 LOGIQ P5
      • 6.6.10.4 LOGIQ E9
      • 6.6.10.5 LOGIQ P6
      • 6.6.10.6 LOGIQ e
      • 6.6.10.7 Venue 40
      • 6.6.10.8 LOGIQ BOOK XP Enhanced
      • 6.6.10.9 LOGIQ P3
      • 6.6.10.10 LOGIQ S7
      • 6.6.10.11 LOGIQ A5
      • 6.6.10.12 Voluson E8 Expert
      • 6.6.10.13 Voluson i
      • 6.6.10.14 Voluson E6
      • 6.6.10.15 Voluson S8
      • 6.6.10.16 Voluson e
      • 6.6.10.17 Voluson S6
      • 6.6.10.18 Voluson 730
      • 6.6.10.19 Vivid E9
      • 6.6.10.20 Vivid i
      • 6.6.10.21 Vivid S6
      • 6.6.10.22 Vivid e
      • 6.6.10.23 Vivid q
      • 6.6.10.24 Vivid S5
  • 6.7 Hologic, Inc.
    • 6.7.1 Digital Mammography
      • 6.7.1.1 Dimensions
      • 6.7.1.2 Selenia Digital Mammography
      • 6.7.1.3 SecurView
      • 6.7.1.4 M-Series Analog Mammography
      • 6.7.1.5 StreoLoc
      • 6.7.1.6 Affinity
    • 6.7.2 Breast MRI Sentinelle Coil
    • 6.7.3 Bone Densitometry
      • 6.7.3.1 Discovery
      • 6.7.3.2 Explorer
      • 6.7.3.3 Delphi
      • 6.7.3.4 QDR-4500 DOS Series
    • 6.7.4 Min C-Arm Systems
      • 6.7.4.1 Premier Encore
      • 6.7.4.2 InSight
    • 6.7.5 Extremity MRI
      • 6.7.5.1 C-Scan
      • 6.7.5.2 E-Scan XQ
      • 6.7.5.3 Opera 298
  • 6.8 Philips Healthcare
    • 6.8.1 CT Scanners
      • 6.8.1.1 Brilliance iCT Scanner
      • 6.8.1.2 Ingenuity CT Scanner
      • 6.8.1.3 Brilliance CT 64-Channel Scanner
      • 6.8.1.4 Brilliance CT 16-Slice
      • 6.8.1.5 MX 16FVO CT Scanner
      • 6.8.1.6 Brilliance CT - Big Bore Radiology Configuration
      • 6.8.1.7 MultiDiagnost Eleva
      • 6.8.1.8 EasyDiagnost Eleva DRF
      • 6.8.1.9 Juno DRF
    • 6.8.2 MRI Scanners
      • 6.8.2.1 Ingenia 3.0T MRI
      • 6.8.2.2 Achieva 3.0TTX MRI
      • 6.8.2.3 Achieva 3.0T X-Series MRI
      • 6.8.2.4 Ingenia 1.5T
      • 6.8.2.5 Panorama HFO
      • 6.8.2.6 Achieva 1.5T A-Series
      • 6.8.2.7 Achieva 1.5T SE
    • 6.8.3 Mobile C-Arms
      • 6.8.3.1 Veradius Neo
      • 6.8.3.2 BV Pulsera
      • 6.8.3.3 BV Endura
    • 6.8.4 Nuclear Medicine
      • 6.8.4.1 BrightView XCT
      • 6.8.4.2 BrightView X
      • 6.8.4.3 CardioMD
    • 6.8.5 Digital Radiography
      • 6.8.5.1 DigitalDiagnost
      • 6.8.5.2 MobileDiagnost wDR
      • 6.8.5.3 EasyDiagnost Eleva DRF
    • 6.8.6 Cardiology Ultrasound
      • 6.8.6.1 iE33 xMATRIX Echocardiography System
      • 6.8.6.2 CX50 xMATRIX CompactXtreme Ultrasound System
      • 6.8.6.3 HD15 PureWave Ultrasound System
      • 6.8.6.4 CX30 CompactXtreme Ultrasound System
      • 6.8.6.5 HD 11 XE Ultrasound System
      • 6.8.6.6 HD7 XE
      • 6.8.6.7 HD7 Ultrasound System
      • 6.8.6.8 HD6 Ultrasound System
      • 6.8.6.9 ClearVue 550 Ultrasound System
      • 6.8.6.10 ClearVue 350 Ultrasound System
    • 6.8.7 Ultrasound Systems for Critical Care
      • 6.8.7.1 SparQ Ultrasound System
    • 6.8.8 Women's Healthcare
      • 6.8.8.1 MicroDose SI Mammography
      • 6.8.8.2 iU22 xMATRIX Ultrasound System
      • 6.8.8.3 Elite Breast MRI
  • 6.9 Positron Corporation
    • 6.9.1 Attrius
    • 6.9.2 PosiRx
    • 6.9.3 Radiopharmaceuticals
    • 6.9.4 Radioisotopes
    • 6.9.5 Tech-Assist
  • 6.10 Siemens Healthcare
    • 6.10.1 Siemen's Universal Angiography Systems
      • 6.10.1.1 Artis Zeego
      • 6.10.1.2 Artis Zee (Ceiling-Mounted System)
      • 6.10.1.3 Artis Zee (Floor-Mounted System)
    • 6.10.2 Neuro-Angiography Systems
      • 6.10.2.1 Artis Zee Biplane System
      • 6.10.2.2 Artis Zee Multipurpose System
    • 6.10.3 Computed Tomography Systems
      • 6.10.3.1 SOMATOM Definition Flash
    • 6.10.4 Multislice CT Systems
      • 6.10.4.1 SOMATOM Definition Edge
      • 6.10.4.2 SOMATOM Definition AS
      • 6.10.4.3 SOMATOM Perspective
      • 6.10.4.4 SOMATOM Sensation
      • 6.10.4.5 SOMATOM Emotion
      • 6.10.4.6 SOMATOM Spirit
      • 6.10.4.7 SOMATOM Sensation Open
    • 6.10.5 Fluoroscopy
      • 6.10.5.1 The New Luminos dRF
      • 6.10.5.2 Luminos Agile
      • 6.10.5.3 Artis Zee (Multipurpose System)
    • 6.10.6 MRI Systems
      • 6.10.6.1 MAGNETOM Aera 1.5T
      • 6.10.6.2 MAGNETOM Skyra
      • 6.10.6.3 MAGNETOM Espree 1.5T
      • 6.10.6.4 MAGNETOM Verio 3T
      • 6.10.6.5 MAGNETOM Avanto 1.5T
      • 6.10.6.6 MAGNETOM Spectra 3T
      • 6.10.6.7 MAGNETOM C! 0.35T
      • 6.10.6.8 MAGNETOM Essenza 1.5T
      • 6.10.6.9 Biograph mMR
    • 6.10.7 PET/CT Systems
      • 6.10.7.1 New Biograph mCT
      • 6.10.7.2 Biograph mCT 20 Excel
      • 6.10.7.3 Biograph TruePoint PET/CT
    • 6.10.8 SPECT & SPECT/CT Systems
      • 6.10.8.1 Symbia T Series
    • 6.10.9 Radiography Systems
      • 6.10.9.1 Digital X-Ray Ysio
      • 6.10.9.2 Multix Fusion
      • 6.10.9.3 Mobilett Mira
      • 6.10.9.4 Mobilett HP Digital
      • 6.10.9.5 Mobilett XP Hybrid
    • 6.10.10 Surgical C-Arms and Navigation Systems
      • 6.10.10.1 Arcadis Avantic
      • 6.10.10.2 Arcadis Orbic 3-D
      • 6.10.10.3 Arcadis Orbic
      • 6.10.10.4 Arcadis Varic
      • 6.10.10.5 Siremobil Compact L
    • 6.10.11 Cardiovascular Ultrasound Systems
      • 6.10.11.1 Acuson SC2000
      • 6.10.11.2 Acuson S2000
      • 6.10.11.3 Acuson S2000 Cardiovascular
      • 6.10.11.4 Acuson X700
      • 6.10.11.5 Acuson X300
      • 6.10.11.6 Acuson P300
      • 6.10.11.7 Acuson P10
  • 6.11 Toshiba Medical Systems Corporation
    • 6.11.1 Computed Tomography Systems
    • 6.11.1.1 Aquilion ONE VISION Edition
      • 6.11.1.2 Aquilion ONE
      • 6.11.1.3 Aquilion PRIME
      • 6.11.1.4 Aquilion CXL-Series
      • 6.11.1.5 Aquilion LB
      • 6.11.1.6 Alexion 348
    • 6.11.2 Magnetic Resonance Imaging
      • 6.11.2.1 Vantage Titan
      • 6.11.2.2 Vantage Atlas
      • 6.11.2.3 Vantage
    • 6.11.3 Ultrasound Systems
      • 6.11.3.1 Artida 4-D
      • 6.11.3.2 Artida 2-D
      • 6.11.3.3 Aplio CV
      • 6.11.3.4 Aplio 500
      • 6.11.3.5 Aplio 400
      • 6.11.3.6 Aplio 300
      • 6.11.3.7 Xario
      • 6.11.3.8 Viamo
      • 6.11.3.9 Nemio MX
    • 6.11.4 X-Ray Systems
      • 6.11.4.1 Infinix CF-i/SP
      • 6.11.4.2 Infinix CC-i
      • 6.11.4.3 Infinix VF-i/BP
      • 6.11.4.4 Infinix VC-i
      • 6.11.4.5 Infinix DP-i
      • 6.11.4.6 Ultimax-i
      • 6.11.4.7 Zexira FPD Version
      • 6.11.4.8 ZEXIRA I.I. Version
      • 6.11.4.9 Winscope Plessart
      • 6.11.4.10 Plessart VIVO
      • 6.11.4.11 Radrex-i
      • 6.11.4.12 Clearscope 1000
      • 6.11.4.13 IME 100 L
  • 6.12 Siemens Healthcare
    • 6.12.1 Siemens' Products for Interventional Radiology
      • 6.12.1.1 Artis Zee Biplane System
      • 6.12.1.2 Artis Zeego
      • 6.12.1.3 Artis Zee Ceiling-Mounted System
      • 6.12.1.4 Artis Zee Floor-Mounted System
    • 6.12.2 Siemens' Interventional Cardiology Products
      • 6.12.2.1 Artis Zeego Multi-Axis System
      • 6.12.2.2 Artis Zee Magnetic Navigation System
    • 6.12.3 Computed Tomography from Siemens
      • 6.12.3.1 SOMATOM Definition Flash
      • 6.12.3.2 SOMATOM Definition Edge
      • 6.12.3.3 SOMATOM Perspective
      • 6.12.3.4 SOMATOM Spirit
      • 6.12.3.5 SOMATOM Definition AS
      • 6.12.3.6 SOMATOM Emotion
    • 6.12.4 Fluoroscopy Offering from Siemens
      • 6.12.4.1 Luminos dRF
      • 6.12.4.2 Luminos Select
      • 6.12.4.3 Luminos Fusion
      • 6.12.4.4 Luminos RF Classic
      • 6.12.4.5 Luminos Agile
    • 6.12.5 MRI from Siemens
      • 6.12.5.1 MAGNETOM Aera
      • 6.12.5.2 MAGNETOM Avanto
      • 6.12.5.3 MAGNETOM Essenza
      • 6.12.5.4 Mobile MRI
      • 6.12.5.5 MAGNETOM Espree
      • 6.12.5.6 MAGNETOM Espree-Pink
      • 6.12.5.7 MAGNETOM C! 0.35T
      • 6.12.5.8 MAGNETOM Skyra
      • 6.12.5.9 MAGNETOM Spectra
      • 6.12.5.10 MAGNETOM Verio
      • 6.12.5.11 MAGNETOM Trio
      • 6.12.5.12 Biograph mMR
    • 6.12.6 Mammography
      • 6.12.6.1 MAMMOMAT Inspiration
    • 6.12.7 Molecular Imaging
      • 6.12.7.1 Biograph mCT
      • 6.12.7.2 Biograph TruePoint PET/CT
      • 6.12.7.3 Biograph mCT 20 Excel
      • 6.12.7.4 Symbia T Series SPECT/CT
      • 6.12.7.5 Symbia S
      • 6.12.7.6 Symbia E
      • 6.12.7.7 c.cam
    • 6.12.8 Radiopharmaceuticals
      • 6.12.8.1 Eclipse HP Cyclotron
      • 6.12.8.2 Explora FDG4
      • 6.12.8.3 Explora FM
      • 6.12.8.4 Explora GN
      • 6.12.8.5 Explora LC
    • 6.12.9 Digital X-Ray
      • 6.12.9.1 Ysio
      • 6.12.9.2 Multix Fusion
      • 6.12.9.3 Mobilett Mira
    • 6.12.10 Surgical C-Arms and Navigation
      • 6.12.10.1 ARCADIS Orbic 3-D
      • 6.12.10.2 ARCADIS Orbic
      • 6.12.10.3 ARCADIS Varic
      • 6.12.10.4 ARCADIS Avantic
      • 6.12.10.5 SIREMOBIL Compact L
      • 6.12.10.6 NaviLink
    • 6.12.11 Cardiovascular Ultrasound
      • 6.12.11.1 ACUSON SC2000
      • 6.12.11.2 ACUSON X300 PE
      • 6.12.11.3 ACUSON P10
      • 6.12.11.4 ACUSON S2000
      • 6.12.11.5 ACUSON P300
    • 6.12.12 OB/GYN
      • 6.12.12.1 ACUSON S3000
      • 6.12.12.2 ACUSON X150
      • 6.12.12.3 ACUSON Antares
    • 6.12.13 Radiology
      • 6.12.13.1 ACUSON S2000 ABVS
      • 6.12.13.2 ACUSON S1000
      • 6.12.13.3 ACUSON X700
    • 6.12.14 Point-of-Care
      • 6.12.14.1 ACUSON Freestyle
  • 6.13 Toshiba Medical Systems Corporation
    • 6.13.1 Computwed Tomography
      • 6.13.1.1 Aquilion ONE
      • 6.13.1.2 Aquilion ONE VISION
      • 6.13.1.3 Aquilion PRIME
      • 6.13.1.4 Aquilion CXL-Series
      • 6.13.1.5 Aquilion RXL Series
      • 6.13.1.6 Aquilion LB
      • 6.13.1.7 Alexion Advance Edition
      • 6.13.1.8 Alexion
    • 6.13.2 MRI
      • 6.13.2.1 Vantage Titan
      • 6.13.2.2 Vantage Atlas
      • 6.13.2.3 Vantage
    • 6.13.3 Ultrasound
      • 6.13.3.1 Artida 4-D
      • 6.13.3.2 Artida 2-D
      • 6.13.3.3 Aplio CV
      • 6.13.3.4 Aplio 500
      • 6.13.3.5 Aplio 400
      • 6.13.3.6 Aplio 300
      • 6.13.3.7 Xario
      • 6.13.3.8 Viamo
      • 6.13.3.9 Nemio MX
    • 6.13.4 X-Ray
      • 6.13.4.1 Infinix CF-i/SP
      • 6.13.4.2 Infinix CF-i/BP
      • 6.13.4.3 Infinix CC-i
      • 6.13.4.4 Infinix VF-i/P
      • 6.13.4.5 Infinix VC-i
      • 6.13.4.6 Infinix DP-i
      • 6.13.4.7 Ultimax-i
      • 6.13.4.8 Zexira FPD Vertsion
      • 6.13.4.9 Zexira I.I
      • 6.13.4.10 Winscope Plessart
      • 6.13.4.11 Plessart VIVO
      • 6.13.4.12 Radrex-i
      • 6.13.4.13 Radrex
      • 6.13.4.14 Clearscope 1000
      • 6.13.4.15 IME-100L

APPENDIX

  • Appendix 1: The Market Outlook for Refurbished Medical Devices
    • Appendix 1.1: Regulatory Scenario for Refurbished Medical Devices
    • Appendix 1.2: Refurbished Medical Devices by Product Segment
    • Appendix 1.3: Opportunity for Refurbished Medical Devices by Country
      • Appendix 1.3.1: Global Market for Refurbished Medical Devices
    • Appendix 1.4: Countries with a Positive Environment for Regulatory Devices
      • Appendix 1.4.1: Countries that Discourage the Purchase of Refurbished Medical Devices
      • Appendix 1.4.2: Countries Restricting the Import of Refurbished Medical Devices
      • Appendix 1.4.3: Countries that Ban the Import of Refurbished Medical Devices
    • Appendix 1.5: Refurbished CT Scanner Market
    • Appendix 1.6: Refurbished MRI Scanner Marke
    • Appendix 1.7: Refurbished Ultrasound Scanner Market
    • Appendix 1.8: Refurbished C-Arm Market
    • Appendix 1.9: Market for Refurbished Medical Devices in the U.S.
    • Appendix 1.10: Market for Refurbished Medical Devices in Western Europe
      • Appendix 1.10.1: Opportunities for Refurbished Medical Devices in Benelux
      • Appendix 1.10.2: Opportunities for Refurbished Medical Devices in France
      • Appendix 1.10.3: Opportunities for Refurbished Medical Devices in Germany
      • Appendix 1.10.4: Opportunities for Refurbished Medical Devices in Italy
      • Appendix 1.10.5: Opportunities for Refurbished Medical Devices in Scandiavia
      • Appendix 1.10.6: Opportunities for Refurbished Medical Devices in Spain
      • Appendix 1.10.7: Opportunities for Refurbished Medical Devices in the U.K.
    • Appendix 1.11: Opportunities for Refurbished Medical Devices in Canada
    • Appendix 1.12: Opportunities for Refurbished Medical Devices in Brazil
    • Appendix 1.13: Opportunities for Refurbished Medical Devices in Brazil
    • Appendix 1.14: Opportunities for Refurbished Medical Devices in South Africa
    • Appendix 1.15: Opportunities for Refurbished Medical Devices in Russia
    • Appendix 1.16: Opportunities for Refurbished Medical Devices in India
    • Appendix 1.17: Opportunities for Refurbished Medical Devices in Romania
  • Appendix 2: Long-Term Global Demand for Technetium-99m
    • Appendix 2.1: Substitution of Tc
    • Appendix 2.2: Alternatives for Substitution
    • Appendix 2.3: Stability of Tc Supply
    • Appendix 2.4: Determinants of Change
      • Appendix 2.4.1: Drivers of Increased Demand for Tc
      • Appendix 2.4.2: Major Drivers of Decreased Demand for Tc
    • Appendix 2.5: Global Trends in Tc Demand
      • Appendix 2.5.2: Availability of Cameras
      • Appendix 2.5.3: The SPECT/PET Shift
    • Appendix 2.6: New Radiopharmaceuticals
      • Appendix 2.6.1: Demand Scenario
        • Appendix 2.6.1.1: Key Results of the Survey
        • Appendix 2.6.1.2: Scenario of Tc Demand
  • Appendix 3: X-Ray Usage and Safety
    • Appendix 3.1: Radiation
      • Appendix 3.1.1: Radiation in Medical Imaging
    • Appendix 3.2: Ionizing Radiation: Basic Concepts
      • Appendix 3.2.1: Action of Ionizing Radiation
      • Appendix 3.2.2: Regulatory Agencies and Radiation Effects
      • Appendix 3.2.3: Ionization Radiation: Quantification, Exposure and Risk
      • Appendix 3.2.4: Ionization Radiation: Proper Protection
      • Appendix 3.2.5: Ionizing Radiation: The Pregnant Patient
    • Appendix 3.3: Alternative Non-Radiation Imaging Modalities
      • Appendix 3.3.1: Ultrasound Imaging
      • Appendix 3.3.2: Magnetic Resonance Imaging
  • Appendix 4: Basic Principles of CT Scanning
    • Appendix 4.1: Field of Use
    • Appendix 4.2: Technical Considerations
    • Appendix 4.3: Total Scan Time and Scan Length
      • Appendix 4.3.1: Clinical Requirements
      • Appendix 4.3.2: Gantry Rotation Time
      • Appendix 4.3.3: Detector Array Length
      • Appendix 4.3.4: X-Ray Tube
      • Appendix 4.3.5: Image Quality
      • Appendix 4.3.6: Spatial Resolution
      • Appendix 4.3.7: Contrast Resolution
      • Appendix 4.3.8: Temporal Resolution
      • Appendix 4.3.9: Image Artifacts
      • Appendix 4.3.10: Ionizing Radiation and Patient Dose
      • Appendix 4.3.11: Over-Beaming
      • Appendix 4.3.12: Over-Ranging in Helical Scanning
      • Appendix 4.3.13: Automatic Tube Current Control in CT
      • Appendix 4.3.14: Cardiac Scanning
    • Appendix 4.4: Installation
      • Appendix 4.4.1: Scanner Location
      • Appendix 4.4.2: Room Requirements
      • Appendix 4.4.3: Ancillary Equipment
      • Appendix 4.4.4: Patient Workflow
      • Appendix 4.4.5: Staffing
      • Appendix 4.4.6: Cardiac Procedures
      • Appendix 4.4.7: Information Workflow
  • Appendix 5: Medical Imaging Systems' Service
    • Appendix 5.1: Service Options
    • Appendix 5.2: Benchmarking Costs
    • Appendix 5.3: Cost-Reduction Opportunities
    • Appendix 5.4: Assessing Costs
    • Appendix 5.5: Guide to Managing Costs

INDEX OF FIGURES

  • Figure 2.1: The U.S. Market Share of C-Arms Systems by Vendor, 2012
  • Figure 2.3: Schematic Diagram of a CT Detector Array with Multiple Detector Banks along Z-Axis
  • Figure 2.4: 16-Slice CT Scanner Z-Axis Detector Bank Configurations
  • Figure 2.5: 32- to 40-Slice CT Scanner Z-Axis Detector Bank Configuration
  • Figure 2.6: 64-Slice CT Scanner Z-Axis Detector Bank Configurations
  • Figure 2.7: Siemens' Somatom Definition Dual X-Ray Source CT Scanner
  • Figure 2.8: Wide Bore CT Scanner Detector Configuration
  • Figure 2.9: CT Scanners with 128 to 320 Data Slices: Z-xis Detector Bank Configurations
  • Figure 2.10: Sources for Mo-99 (for Tc-99m)
  • Figure 3.1: Relative Use of Imaging Modalities in Oncology
  • Figure 3.2: Global Prevalence of Cardiovascular Diseases Aged 25+ Years
  • Figure 3.3: Percent of Deaths Due to Cardiovascular Diseases by Ethnicity
  • Figure 3.4: Deaths Due to Cardiovascular Diseases in European Men
  • Figure 3.5: Deaths Due to Cardiovascular Diseases in European Women
  • Figure 3.6: Relative Use of Imaging Modalities in Cardiology
  • Figure 3.7: Relative Use of Imaging Modalities in Neurology
  • Figure 3.8: Relative Use of Imaging Modalities in Bone Scans
  • Figure 4.1: Global Medical Imaging Market, 2012-2019
  • Figure 4.2: Medical Imaging Market Share by Geography, 2012
  • Figure 4.3: Medical Imaging Market by Modality, 2012
  • Figure 4.4: Medical Imaging Market by Care Setting/Application
  • Figure 4.5: U.S. Market for Advanced Imaging Modalities (CT and MRI), 2012-2019
  • Figure 4.6: Average Expenses per Procedure by Modality in the Hospital Setting
  • Figure 4.7: Average Expenses per Procedure by Modality in Freestanding-Imaging-Center Setting
  • Figure 4.8: Exam Mix by Modality and Percentage of Total in Hospitals
  • Figure 4.9: Exam Mix by Modality and Percentage of Total in Outpatient Imaging Centers
  • Figure 4.10: Medicare Spending for Imaging Services under the Physician Fee Schedule by Type of Service
  • Figure 4.11: Rapid Growth in the Number of CT and MRI Scans per 1,000 Beneficiaries
  • Figure 4.12: Cumulative per Beneficiary Spending Change since 2006 for Imaging and Non Imaging Services for Medicare Carrier Paid Claims
  • Figure 4.13: Cumulative per Beneficiary Utilization Change Since 2006 for Imaging and Non-Imaging Services for Medicare Carrier Paid Claims
  • Figure 4.14: Imaging Spending as a Percentage of Total Medicare Carrier Paid Claims
  • Figure 4.15: Medicare Part B Annual Rate of Growth in Assigned Services by Procedure Category
  • Figure 4.16: Medicare Part B Annual Program Dollars Spent per Patient by Procedure Category
  • Figure 4.17: Growth/Decline of the U.S. Imaging Center Chains, 2003-2011
  • Figure 4.18: Growth/Decline of Imaging Centers Owned, Managed or Leased in the U.S.
  • Figure 4.19: Growth/Decline in Top Three Imaging Center Chains, 2007-2011
  • Figure 4.20: Affiliation of Imaging Centers with Chains, 2003-2011
  • Figure 4.21: Number of Imaging Centers Affiliated with Integrated Halth Networks, 2002-2011
  • Figure 4.22: Average Number of Imaging Procedures per Week
  • Figure 4.23: Rising Demand for MRI/CT Exams in Canada
  • Figure 4.24: Number of Selected Medical Imaging Equipment in Canadian Hospitals, 2012
  • Figure 4.25: Number of Selected Medical Imaging Equipment in Alberta, 2012
  • Figure 4.26: Number of Selected Medical Imaging Equipment in British Columbia, 2012
  • Figure 4.27: Number of Selected Imaging Equipment in Manitoba, 2012
  • Figure 4.28: Number of Selected Imaging Equipment in New Brunswick, 2012
  • Figure 4.29: Number of Selected Medical Imaging Equipment in Newfoundland and Labrador, 2012
  • Figure 4.30: Number of Selected Medical Imaging Equipment in Nova Scotia, 2012
  • Figure 4.31: Number of Selected Medical Imaging Equipment in Ontario, 2012
  • Figure 4.32: Number of Selected Medical Imaging Equipment in Quebec, 2012
  • Figure 4.33: Segmentation of Diagnostic Imaging Equipment in Canada
  • Figure 4.34: Diagnostic Imaging Market in Germany, 2012-2019
  • Figure 4.35: Diagnostic Imaging Market in France, 2012-2019
  • Figure 4.36: Diagnostic Imaging Market in Italy, 2012-2019
  • Figure 4.37: Diagnostic Imaging Market in Spain, 2012-2019
  • Figure 4.38: Diagnostic Imaging Market in U.K., 2012-2019
  • Figure 4.39: CT and MRI Imaging Examinations in U.K.
  • Figure 4.40: Projected and Actual Replacement of CT Scanners in U.K.
  • Figure 4.41: Projected and Actual Replacement of MRI Scanners in U.K.
  • Figure 4.42: Comparison of Diagnostic Imaging Markets in Europe by Country, 2012-2019
  • Figure 4.43: Sustained Growth of Medical Imaging in Pharmerging Markets
  • Figure 4.44: Medical Imaging Revenues in Asia/Pacific, 2012-2019
  • Figure 4.45: Medical Imaging Market in Japan, 2012-2019
  • Figure 4.46: Medical Imaging Market in China, 2012-2019
  • Figure 4.47: Medical Imaging Market in South Korea, 201-2019
  • Figure 4.48: Medical Imaging Market in Australia, 2012-2019
  • Figure 4.49: Medical Imaging Market in India, 2012-2019
  • Figure 4.50: Global Market for X-Ray Systems, 2012-2019
  • Figure 4.51: Increasing Share of Mobile X-ray Systems in the Global X-Ray Market, 2012-2019
  • Figure 4.52: Global Market for Fluoroscopy and Mobile C-Arm Systems, 2012-2019
  • Figure 4.53: Global Market for DR and CR X-Ray Systems, 2012-2019
  • Figure 4.54: U.S. Market for X-Ray Systems, 2012-2019
  • Figure 4.55: European Market for X-Ray Systems, 2012-2019
  • Figure 4.56: Overall X-Ray Market in China, 2012-2019
  • Figure 4.57: Value of Indian X-Ray Market
  • Figure 4.58: Indian Market for DR Systems
  • Figure 4.59: Global Full-Field Digital Mammography Equipment Market, 2012-2019
  • Figure 4.60: Share of Global FFDM Market Share by Company
  • Figure 4.61: U.S. Full-Field Digital Mammography Market, 2012-2019
  • Figure 4.62: Global Market for Bone Densitometry Systems, 2012-2019
  • Figure 4.63: Global Market for CT Scanners, 2012-2019
  • Figure 4.64: U.S. Market for CT Scanners, 2012-2019
  • Figure 4.65: Deployed CT Systems by Slice Count in the U.S.
  • Figure 4.66: Total CT Procedure Volume in the U.S.
  • Figure 4.67: CT Utilization Percentage by System Age in the U.S.
  • Figure 4.68: Service Providers for CT Systems
  • Figure 4.69: Average Annual CT Service Cost per System by Slice Count
  • Figure 4.70: The Average Age of CT Systems
  • Figure 4.71: Number of Self-Referred and Non-Self-Referred CT Services in the U.S.
  • Figure 4.72: Self-Referred and Non-Self-Referred CT Expenditure in the U.S.
  • Figure 4.73: Growth in Volumes of CT Exams Performed in Canada, 2003-2011
  • Figure 4.74: European Market for CT Systems, 2012-2019
  • Figure 4.75: Units of CT Market in Western Europe by Slice Count, 2012-2019
  • Figure 4.76: CT Equipment Market in Austria and Switzerland by Slice Count
  • Figure 4.77: CT Equipment Market in Benelux by Slice Count
  • Figure 4.78: CT Equipment Market in France by Slice Count
  • Figure 4.79: CT Equipment Market in Germany by Slice Count
  • Figure 4.80: CT Equipment Market in Italy by Slice Count
  • Figure 4.81: CT Equipment Market in Spain and Portugal
  • Figure 4.82: CT Equipment Market in U.K. and Ireland
  • Figure 4.83: CT Exams in OECD Countries
  • Figure 4.84: CT Scanners in OECD Countries
  • Figure 4.85: Indian CT Scanners Market Value-Wise, 2010 ($113 Million)-2011 ($150 Million)
  • Figure 4.86: Indian CT Scanners Market (Total = $150 Million) Share by Segment
  • Figure 4.87: Global Market for MRI, 2012-2019
  • Figure 4.88: U.S. Market for MRI, 2012-2019
  • Figure 4.89: Deployed MRI Systems by Field Strength in the U.S.
  • Figure 4.90: MRI Utilization Percentage by System Age in the U.S.
  • Figure 4.91: Service Providers for MRI Systems
  • Figure 4.92: Average Annual MRI Service Cost per System by Field-Strength
  • Figure 4.93: Distribution of Advanced Imaging Services by Modality and Setting
  • Figure 4.94: Number of Self-Referred and Non-Self-Referred MRI Services in the U.S.
  • Figure 4.95: Self-Referred and Non-Self-Referred MRI Expenditures in the U.S.
  • Figure 4.96: Growth in Number of MRI and CT Scans per 1,000 Beneficiaries in the U.S.
  • Figure 4.97: Growth in Volume of MRI Exams Performed in Canada, 2003-2011
  • Figure 4.98: MRI Scans Completed and Ordered in Ontario, 2008-2011
  • Figure 4.99: European Market for MRI Systems, 2012-2019
  • Figure 4.100: MRI and CT Exams in U.K.
  • Figure 4.101: Number of CT, MRI and LINAC Machines Purchased by NHS
  • Figure 4.102: MRI Units per Million Populations in OECD Countries
  • Figure 4.103: MRI Exams in OECD Countries
  • Figure 4.104: MRI Market in Japan, 2012-2019
  • Figure 4.105: Indian MRI Market Value-Wise ($157 million), March 2012
  • Figure 4.106: MRI Market in China, 2012-2019
  • Figure 4.107: Global Market for Ultrasound Systems, 2012-2019
  • Figure 4.108: Breakdown of Clinical Specialties in the Ultrasound Market
  • Figure 4.109: Breakdown of Clinical Specialties in the Ultrasound Market and Growth Rates
  • Figure 4.110: U.S. Ultrasound in Interventional Radiology: Unit Shipments, 2011-2015
  • Figure 4.111: European Market for Ultrasound Systems, 2012-2019
  • Figure 4.112: Chinese Market for Ultrasound by Product Type
  • Figure 4.113: Indian Ultrasound Equipment Market ($140 Million) Value-Wise, 2012
  • Figure 4.114: Indian Ultrasound Equipment Market Unit-Wise, 2012
  • Figure 4.115: Indian Color Doppler Equipment Market Value-Wise ($129 Million), 2012
  • Figure 4.116: Indian Color Doppler Equipment Market Unit-Wise (Total = 4,980 units), 2012
  • Figure 4.117: Global Market for Nuclear Imaging Systems, 2012-2019
  • Figure 4.118: Nuclear Imaging Equipment Market Share by Vendor
  • Figure 4.119: U.S. Market for Nuclear Imaging Systems, 2012-2019 2
  • Figure 4.120: European Market for Molecular Imaging, 2012-2019
  • Figure 4.121: European Nuclear Imaging Market by Segment
  • Figure 4.122: Global Market for PET Imaging Systems, 2012-2019
  • Figure 4.123: Geographical Share of PET and PET/CT Systems, 2012
  • Figure 4.124: Growth Rate (%) for PET in the Global Market, 2012-2019
  • Figure 4.125: New and Refurbished PET Sales in the U.S., 2012-2019
  • Figure 4.126: Sales of Refurbished PET Systems in the U.S., 2012-209
  • Figure 4.127: Nuclear Equipment, Average Selling Price in the U.S. and the U.K.
  • Figure 4.128: Total Nuclear Medicine Procedure Volume in the U.S.
  • Figure 4.129: Growth Rate for PET in the U.S., 2012-2019
  • Figure 4.130: Distribution of PET Imaging Sites as of 2011 in the U.S.
  • Figure 4.131: PET Imaging Sites and Patient Studies by Site Type
  • Figure 4.132: Pet Imaging Sites and Patient Studies by Current PET Capability
  • Figure 4.133: Distribution of Fixed PET/CT and PET Scanners by Hospital and Non-Hospital Sites
  • Figure 4.134: Mobile vs. Fixed PET/CT and PET Sites
  • Figure 4.135: Fixed and Mobile PET/CT or PET Sites and Units
  • Figure 4.136: Clinical PET Patient Studies by Site Type, 2005-2011
  • Figure 4.137: Percentage of Sites Performing Research vs. Clinical Studies
  • Figure 4.138: Percent Distribution of Fixed PET/CT and PET (1,310) Scanners in the U.S.
  • Figure 4.139: Percent Distribution of PET/CT Installed Base (1,555) by Number of CT Slices
  • Figure 4.140: U.S. Cardiac PET/CT Market, 2012-2019
  • Figure 4.141: Estimated Global Orders for PET/MR Systems, 2012-2019
  • Figure 4.142: U.S. Orders for PET/MR, 2012-2019
  • Figure 4.143: Cost of PET Scans across Canada
  • Figure 4.144: Growth of PET and PET/CT Centers in Europe, 2002-2012
  • Figure 4.145: Growth of PET and PET/CT Centers in France, 2002-2012
  • Figure 4.146: Growth of PET and PET/CT Centers in Germany, 2002-2012
  • Figure 4.147: Growth of PET and PET/CT Centers in U.K., 2004-2012
  • Figure 4.148: Growth of PET and PET/CT Centers in Emerging Markets by Country, 2012
  • Figure 4.149: Growth of PET and PET/CT Centers in Emerging Markets, 2004-2012
  • Figure 4.150: Indian Nuclear Medicine Equipment Market by Number of Units
  • Figure 4.151: U.S. Sales of SPECT Systems, 2012-2019
  • Figure 4.152: Average Income from One SPECT Imaging System for a Facility in the U.S.
  • Figure 5.1: Relative Use of CT, MRI, Ultrasound, PET and SPECT, 2008-2025
  • Figure 5.2: Relative Use of PET/CT, PET/MR, SPECT/CT and SPECT/MRI, 2008-2025
  • Figure 5.3: Share of the Number of Scans According to Base Modalities, 2008-2025
  • Figure 5.4: Breakdown of the Shares of SPECT Modalities
  • Figure A.1.1: Global Refurbished Medical Device Market Size, 2005-2010
  • Figure A.1.2: Global Refurbished Medical Device Market Size, 2011-2016
  • Figure A.1.3: Revenue Split for Refurbished Medical Devices by Product Type, 2010
  • Figure A.1.4: Estimated Revenue for Refurbished Medical Device Market by Geography, 2010-2016
  • Figure A.2.1: Major Alternatives Expected to Replace Tc
  • Figure A.2.2: Percentage of Users Who Experienced the Effects of Tc Shortage
  • Figure A.2.3: Expected Stability of Tc Supply
  • Figure A.2.4: Geographical Expectations on Stability of Supply of Tc
  • Figure A.2.5: Major Drivers of Increased Demand for Tc
  • Figure A.2.6: Drivers of Decreasing Demand for Tc 4
  • Figure A.2.7: Estimated Global (Excluding North Amrica) Sales of PET and SPECT Cameras by Number
  • Figure A.2.8: The Forecasted Mo Demand per Week
  • Figure A.4.1: Schematic Diagram of CT Scanner "End-ViewH
  • Figure A.4.2: Schematic Diagram of CT Scanner "Side-View" in Helical Acquisition Mode
  • Figure A.4.3: Multi-Slice CT Scanner X-Ray Beam and Detectors Approximately to Scale
  • Figure A.4.4: Multi-Slice CT Scanner X-Ray Beam and Detectors Schematic
  • Figure A.4.5: Technological Advances in CT Scanner Technology, 1985-2008
  • Figure A.4.6: Effect of Detector Array on Number of Rotations and Scan Time
  • Figure A.4.7: Example of 16 Slice Detector with Reduced Coverage for Fine Slces
  • Figure A.4.8: Examples of Fixed and Variable Z-Axis Detector Arrays
  • Figure A.4.9: CT Perfusion with Jog or Shuttle Scan
  • Figure A.4.10: Test Object with Line Pairs of Varying Frequencies for Assessment of Scan Plane Spatial Resolution
  • Figure A.4.11: Diagram of Methods for Improving Sampling Density (a) Quarter Detector Shift, (b) Flying Focal Spot
  • Figure A.4.12: Reduction of Effective Detector Size with Attenuating Grid
  • Figure A.4.13: Test Object for Contrast Resolution Measurements
  • Figure A.4.14: Principle of Multi-Segment Reconstruction in Retrospectively Gated CCTA
  • Figure A.4.15: Schematic Diagram of a Dual Source CT Scanner
  • Figure A.4.16: CT Scan Through Shoulders, Demonstrating Photon Starvation Artifacts
  • Figure A.4.17: PMMA Body Phantom Used for Measurement of CT Doses
  • Figure A.4.18: Illustration of CTDIvol Representing Average Dose at Central Slice Position of 100 mm Irradiation Length
  • Figure A.4.19: Reduced Influence of Over-Beaming for Larger Z-Axis Beam Collimations
  • Figure A.4.20: Increased Contribution from Over-Ranging with Wider X-Ray Collimations
  • Figure A.4.21: Dynamic Collimation to Reduce Dose at the Extremities of a Scan
  • Figure A.4.22: Automatic Tube Current Control in CT
  • Figure A.4.23: ECG-Gated Tube Current Modulation
  • Figure A.4.24: The Stages of a CT Scan
  • Figure A.4.25: Examples of Allocation of Specific Roles to Assist Patient Workflow
  • Figure A.4.26: Information and Image Flow

INDEX OF TABLES

  • Table 2.1: Features of Some of the Largest Selling CR Systems
  • Table 2.2: Detector Types in Selected DR Systems
  • Table 2.3: Dimensions (inches) of C-Arms
  • Table 2.4: Comparison of Generator Power kW) in C-Arms Systems
  • Table 2.5: Image Intensifier Sizes (inches) and Focal Spot Sizes (mm) in C-Arms Systems
  • Table 2.6: Image Display (inches) and Image Resolution in C-Arm Systems
  • Table 2.7: X-Ray Tube Types in C-Arms Systems
  • Table 2.8: Depth of C (inches) in C-Arm Systems
  • Table 2.9: CRA/CAU Angulation (degrees) in C-Arms Systems
  • Table 2.10: LAO/RAO Rotation (degrees) in C-Arms Systems
  • Table 2.11: Pulsed Fluoro Rates (PPS) in C-Arms Systems
  • Table 2.12: Price Variations in Refurbished C-Arms Systems
  • Table 2.13: C-Arms Systems Investment Analysis for OEC 9600
  • Table 2.14: Detector Technologies Used in FFDM Systems
  • Figure 2.2: Annual Incidence of Osteoporotic Fracture vs. Other Diseases in the U.S. Females
  • Table 2.15: Selected Multi-Slice CT Scanners
  • Table 2.16: Scanner Z-Axis Detector Array Configurations
  • Table 2.17: 16-slice scanners
  • Table 2.18: 32- to 40-Slice CT Scanners
  • Table 2.19: 64-Slice CT Scanners
  • Table 2.20: Wide Bore CT Scanners
  • Table 2.21: Greater Than 64-Slice CT Scanners
  • Table 2.22: Technical Specifications for 1.5T Systems
  • Table 2.23: Technical Specifications for 3 T Systems
  • Table 2.24: Patient Comfort in 1.5T Models
  • Table 2.25: Patient Comfort in 3T Models
  • Table 2.26: Radionuclides Used in SPECT Imaging
  • Table 2.27: Clinical SPECT/CT Devices
  • Table 2.28: Important Characteristicsof Selected Imaging Techniques
  • Table 3.1: Estimated New Cancer Cases and Deaths by Sex in the U.S., 2012
  • Table 3.2: Deaths Attributable to Neurological Disorders as Percentage of Total Deaths
  • Table 4.1: Average Revenue (Blended) per Procedure, Comparing Hospital and Outpatient Imaging Center Technical-Component Reimbursement
  • Table 4.2: CT and MRI Systems in Six States in the U.S.
  • Table 4.3: Projected Postreform in Medical Imaging in the U.S.
  • Table 4.4: Current and Post-reform CT and MRI Needs and Capacities
  • Table 4.5: Estimated State-by-State Impact of Healthcare Reform on Imaging Use
  • Table 4.6: States with the Highest Projected Imaging Growth
  • Table 4.7: States with the Lowest Projected Imaging Growth
  • Table 4.8: Growth by Modality in Texas and Massachusetts3
  • Table 4.9: Affiliated Imaging-Center Chains in the U.S., 2000-2012
  • Table 4.10: Imaging-Center Chain Growth, 2003-2012
  • Table 4.11: Top 20 Imaging-Center Chains in the U.S, 2010-2012
  • Table 4.12: Integrated Health Networks Centers
  • Table 4.13: Growth/Decline of Imaging Centers by Region, 2010-2011
  • Table 4.14: Integrated Health Networks with the Most Imaging-Center Relationships
  • Table 4.15: Average Patient Visits by Imaging Center by Region in the U.S.
  • Table 4.16: CT Exams per 1,000 People in the U.S. by Region
  • Table 4.17: CT Procedure Predicted Growth in the U.S., 2011-2016
  • Table 4.18: Changes to Reimbursement for CT Imaging, 2013
  • Table 4.19: MRI Procedure Growth in the U.S.
  • Figure 4.20: Average Cost of MRI Procedures in the U.S. Facilities
  • Table 4.21: MRI Exams per 1,000 People in the U.S.
  • Table 4.22: CT and MRI Systems in Six States of the U.S.
  • Table 4.23: Projected Post-Reform Revenue Increases
  • Table 4.24: Current and Post-Reform CT and MRI Needs and Capacities
  • Table 4.25: Distribution of Clinical PET Oncology Patient Studies
  • Table 4.26: Location of Publicly-Funded Clinical Pet Scanners in Canada, 2011
  • Table 6.1: Radiopharmaceuticals Offered by Positron
  • Table 6.2: Radioisotopes from Positron
  • Table A.1.1: Countries Permitting the Import of Refurbished Medical Devices
  • Table A.1.2: Countries Discouraging Purchase of Refurbished Medical Devices
  • Table A.1.3: Countries Restricting the Import of Refurbished Medical Devices
  • Table A.2.1: Expected Tc Demand Growth
  • Table A.3.1: Ionizing and Non-Ionizing ources of Radiation
  • Table A.3.2: The Contribution of the Common Sources of Radiation
  • Table A.3.3: Radiation Dose for Various Imaging Procedures Compared to Background Radiation
  • Table A.3.4: Dose Limits Recommended for Planned Exposure Situations
  • Table A.3.5: Radiation Induced Malformations from Fetal Exposures
  • Table A.3.6: Estimates of Fetal Radiation Doses from Common Imaging Diagnostic Procedures
  • Table A.5.1: Annual Cost of Service as a Percentage of Equipment Cost
Show More
Pricing
Get Notified
Email me when related reports are published